Drug recall · June 21, 2023
Tranexamic Acid USP Tablets recall
Why: Failed Impurities/Degradation Specifications: Out of specification results obtained for conductivity.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Tranexamic Acid USP Tablets, 650 mg, 30 tablets (3X10) Unit Dose, Rx Only, Manufactured for: AvKARE Pulaski, TN 38478, NDC 50268-772-13
- Lots / codes
Lot: 44286 Exp. 02/2025
- Quantity
- 592 cartons
- Company
- Avkare LLC, Pulaski, TN
- Distribution
- Nationwide in the USA.
- Initiated
- June 13, 2023 · Voluntary: Firm initiated
- Classified
- June 15, 2023
- Reported
- June 21, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Tranexamic acid
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.